{"id":28381,"date":"2026-05-01T22:05:07","date_gmt":"2026-05-01T22:05:07","guid":{"rendered":"https:\/\/www.europesays.com\/canada\/28381\/"},"modified":"2026-05-01T22:05:07","modified_gmt":"2026-05-01T22:05:07","slug":"health-canada-approves-2nd-generic-version-of-ozempic-and-its-canadian-4","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/canada\/28381\/","title":{"rendered":"Health Canada approves 2nd generic version of Ozempic \u2014 and it&#8217;s Canadian"},"content":{"rendered":"<p class=\"mb-4 text-lg md:leading-8 break-words\">Health Canada has approved the second generic version of brand-name Ozempic, this one manufactured by Canadian company Apotex.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">The authorization comes just <a data-yga=\"{\" ylinkelement=\"\" href=\"https:\/\/www.cbc.ca\/news\/health\/ozempic-generic-health-canada-9.7180566\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"elm:link;elmt:article_link;slk:three days after;itc:0;sec:content-canvas\" class=\"link \">three days after<\/a> Health Canada approved the first generic semaglutide \u2014 the active ingredient in Novo Nordisk&#8217;s Ozempic \u2014 made by Dr. Reddy&#8217;s Laboratories in India.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">The injectable medications are approved for the treatment of Type 2 diabetes in adults, but Ozempic is often prescribed off-label for weight loss.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">Canada is the first of the G7 countries to authorize generic semaglutide.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">Apotex is a global pharmaceutical company headquartered in Toronto.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">Many people without drug coverage have been eagerly waiting for generic semaglutide because the brand name original can cost hundreds of dollars a month. Depending on the dose, people can pay about <a data-yga=\"{\" ylinkelement=\"\" href=\"https:\/\/www.cbc.ca\/news\/health\/generic-ozempic-canada-waiting-9.7142339\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"elm:link;elmt:article_link;slk:$300 to $400;itc:0;sec:content-canvas\" class=\"link \">$300 to $400<\/a>, sometimes even more, per month.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">How much cheaper generic semaglutide will be than Ozempic depends on how many generic options are approved and hit the market, say experts.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">According to the pricing structure of the pan-Canadian Pharmaceutical Alliance, the first generic medication could cost 75 to 85 per cent of the brand name. Once a second medication enters the market, the price for both drops to 50 per cent.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">When there are three or more generic products available in Canada, the cost would decrease to about 35 per cent of brand-name Ozempic&#8217;s price.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">Drug shows benefits, but experts caution its use <\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">Recent research continues to boast broad benefits for semaglutide drugs, including impacts on <a data-yga=\"{\" ylinkelement=\"\" href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12413075\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"elm:link;elmt:article_link;slk:inflammation;itc:0;sec:content-canvas\" class=\"link \">inflammation<\/a>, <a data-yga=\"{\" ylinkelement=\"\" href=\"https:\/\/www.nature.com\/articles\/s41584-025-01302-0.epdf?sharing_token=AMgNAO5-xNo0TGVNkulsxdRgN0jAjWel9jnR3ZoTv0MKSdib8dumQr8yCAfPUxh6S_U2SbPFx3-Agjh_P7H1xiMSYzpyrHaugYh1iTvDk2kWsI2mJ1rajeht9RSkEod4sIW_jcPS4PYCLJ6a7e7Pj0qxXMWm6eelWM9wXb8o9Kg%3D\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"elm:link;elmt:article_link;slk:arthritis;itc:0;sec:content-canvas\" class=\"link \">arthritis<\/a> and lowering <a data-yga=\"{\" ylinkelement=\"\" href=\"https:\/\/link.springer.com\/article\/10.1186\/s40842-026-00295-3\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"elm:link;elmt:article_link;slk:the risk of major cardiac events, stroke and early death;itc:0;sec:content-canvas\" class=\"link \">the risk of major cardiac events, stroke and early death<\/a>.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">&#8220;That&#8217;s remarkable. There aren&#8217;t many drugs that have had that degree of study going on,&#8221; said Dr. Hertzel Gerstein, a diabetes doctor and researcher in Hamilton.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">But, he also cautions their use.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">&#8220;They&#8217;re not supplements, they&#8217;re not over-the-counter things,&#8221; said Gerstein, who is also the director of the Population Health Research Institute jointly run by McMaster University and Hamilton Health Sciences.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">&#8220;They&#8217;re powerful drugs. They do good things. They can be taken in a wrong way, and that can cause problems and side effects.&#8221;<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">Before getting on a weight loss drug, he said people should speak to a health-care professional.<\/p>\n","protected":false},"excerpt":{"rendered":"Health Canada has approved the second generic version of brand-name Ozempic, this one manufactured by Canadian company Apotex.&hellip;\n","protected":false},"author":2,"featured_media":28382,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[13375,13373,17,13370,13371,13372,1855,13374,13377,13376,13378],"class_list":["post-28381","post","type-post","status-publish","format-standard","has-post-thumbnail","category-canada","tag-apotex","tag-brand-name","tag-canada","tag-generic-products","tag-generic-version","tag-hamilton-health-sciences","tag-health-canada","tag-hertzel-gerstein","tag-novo-nordisk","tag-ozempic","tag-weight-loss-drug"],"_links":{"self":[{"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/posts\/28381","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/comments?post=28381"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/posts\/28381\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/media\/28382"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/media?parent=28381"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/categories?post=28381"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/tags?post=28381"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}